Trevi Therapeutics Inc (TRVI)
2.865
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
2.865
0.00 (0.00%)
After-Hours: 16:56
Trevi Therapeutics Total Liabilities (Quarterly): 9.939M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.939M |
| June 30, 2024 | 7.636M |
| March 31, 2024 | 6.225M |
| December 31, 2023 | 6.856M |
| September 30, 2023 | 6.286M |
| June 30, 2023 | 5.904M |
| March 31, 2023 | 14.47M |
| December 31, 2022 | 15.56M |
| September 30, 2022 | 18.46M |
| June 30, 2022 | 20.90M |
| March 31, 2022 | 19.92M |
| December 31, 2021 | 21.40M |
| Date | Value |
|---|---|
| September 30, 2021 | 20.22M |
| June 30, 2021 | 21.41M |
| March 31, 2021 | 19.18M |
| December 31, 2020 | 19.85M |
| September 30, 2020 | 20.26M |
| June 30, 2020 | 6.972M |
| March 31, 2020 | 7.436M |
| December 31, 2019 | 5.456M |
| September 30, 2019 | 5.313M |
| June 30, 2019 | 7.413M |
| March 31, 2019 | 4.51M |
| December 31, 2018 | 4.278M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.456M
Minimum
Dec 2019
21.41M
Maximum
Jun 2021
13.72M
Average
15.01M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.91M |
| Shareholders Equity (Quarterly) | 58.97M |